Lillie is a commercial and business development leader with over 15 years of experience building strategic CRO partnerships with emerging and mid-size biotechs and pharmaceutical companies across the United States and Europe. She brings deep expertise in positioning both full-service and FSP models across oncology, rare disease, and specialty indications, helping sponsors identify the most effective operational pathway for their development programs.

Throughout her career, Lillie has worked in close collaboration with clinical operations and biometrics leadership teams to craft credible, delivery-driven proposals grounded in operational realism and strategic alignment. She understands that successful business development extends beyond winning work—it requires building long-term, trust-based partnerships that deliver measurable value.

Her strengths include strategic account management, new logo acquisition, and solution-oriented selling for global clinical development programs. She leads proposal strategy, bid defenses, pricing discussions, and contract negotiations with confidence and commercial clarity, ensuring alignment between sponsor expectations and execution capability. Her collaborative approach, market insight, and commitment to transparency position her as a trusted advisor to sponsors navigating complex global clinical development landscapes.